NYSE:NSRX – SPAC Feed

IL0012181553
NYSE:NSRX

August 13, 2025

Nasus Pharma Announces Pricing of $10 Million Initial Public Offering

TEL AVIV, Israel, Aug. 13, 2025 (GLOBE NEWSWIRE) — Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on…

By sf-admin